[go: up one dir, main page]

MX2020004251A - Composición tópica para cicatrización mejorada de heridas abiertas. - Google Patents

Composición tópica para cicatrización mejorada de heridas abiertas.

Info

Publication number
MX2020004251A
MX2020004251A MX2020004251A MX2020004251A MX2020004251A MX 2020004251 A MX2020004251 A MX 2020004251A MX 2020004251 A MX2020004251 A MX 2020004251A MX 2020004251 A MX2020004251 A MX 2020004251A MX 2020004251 A MX2020004251 A MX 2020004251A
Authority
MX
Mexico
Prior art keywords
topical composition
open wounds
improved healing
concerned
compositions
Prior art date
Application number
MX2020004251A
Other languages
English (en)
Inventor
Mona E Buice
David M Sailors
Jonathan Woody
James Louis Wood
Joshua Z Greeson
Original Assignee
Mona E Buice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mona E Buice filed Critical Mona E Buice
Publication of MX2020004251A publication Critical patent/MX2020004251A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente descripción hace referencia a composiciones que comprenden insulina y un transportador tópico farmacéuticamente aceptable. Además, la presente descripción hace referencia a métodos para usar estas composiciones para el tratamiento de un padecimiento de la piel, tal como una úlcera diabética. Se pretende que este resumen sea una herramienta de análisis con fines de consulta en la técnica concreta y no se pretende que limite la presente invención.
MX2020004251A 2017-10-19 2018-10-19 Composición tópica para cicatrización mejorada de heridas abiertas. MX2020004251A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574481P 2017-10-19 2017-10-19
US201862678574P 2018-05-31 2018-05-31
PCT/US2018/056697 WO2019079710A1 (en) 2017-10-19 2018-10-19 TOPIC COMPOSITION FOR ENHANCED WOUND WOUND HEALING

Publications (1)

Publication Number Publication Date
MX2020004251A true MX2020004251A (es) 2021-05-27

Family

ID=66174274

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020004251A MX2020004251A (es) 2017-10-19 2018-10-19 Composición tópica para cicatrización mejorada de heridas abiertas.
MX2025011487A MX2025011487A (es) 2017-10-19 2020-07-13 Composicion topica para cicatrizacion mejorada de heridas abiertas

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2025011487A MX2025011487A (es) 2017-10-19 2020-07-13 Composicion topica para cicatrizacion mejorada de heridas abiertas

Country Status (8)

Country Link
US (4) US20190290736A1 (es)
EP (1) EP3697433A4 (es)
AU (2) AU2018351352A1 (es)
CA (1) CA3079544A1 (es)
IL (2) IL274002B1 (es)
MA (1) MA50414A (es)
MX (2) MX2020004251A (es)
WO (1) WO2019079710A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3697433A4 (en) 2017-10-19 2021-07-21 Buice, Mona, E. TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS
US11707433B2 (en) * 2019-09-01 2023-07-25 Pathway Development Llc Methods and compositions for treating diabetic foot ulcers
WO2025010400A2 (en) * 2023-07-05 2025-01-09 Eleos Pharmaceuticals, Inc. Compositions and methods for improved treatment of skin wounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6155992A (en) * 1997-12-02 2000-12-05 Abbott Laboratories Method and apparatus for obtaining interstitial fluid for diagnostic tests
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
RU2203500C2 (ru) 2000-10-20 2003-04-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ диагностики ранних стадий диабетической ретинопатии
US20060009373A1 (en) 2004-07-08 2006-01-12 Max Martin Method for treating diabetic wounds
AU2007281433A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
CN102307577A (zh) * 2009-02-13 2012-01-04 贝林格尔.英格海姆国际有限公司 包含sglt2抑制剂、dpp-iv抑制剂和任选的另一种抗糖尿病药的药物组合物及其用途
WO2010097800A1 (en) 2009-02-26 2010-09-02 Muhammad Abdulrazik Synergistic combination of bioactive compounds for lowering of intraocular pressure
US20110294730A1 (en) 2010-05-31 2011-12-01 Shantha Totada R Method of treating glaucoma and intraocular hypertension
US20120003296A1 (en) 2010-07-01 2012-01-05 Shantha Totada R New methods of treating dry eye syndrome
AU2011327785A1 (en) 2010-11-08 2013-03-07 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
AU2012236493A1 (en) 2011-04-01 2013-10-31 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
WO2013141730A1 (en) * 2012-03-19 2013-09-26 Tecnifar-Indústria Técnica Farmacêutica, S.A. Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
CN103566359A (zh) 2012-07-18 2014-02-12 张雅琴 自拟冲洗液加冲吸式换药法治疗糖尿病足的应用
US20160045158A1 (en) 2013-03-15 2016-02-18 Prometheon Pharma, Llc Devices, systems, and methods for transdermal delivery of compounds
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
EP3113764B1 (en) 2014-03-04 2020-07-22 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
US20160220581A1 (en) 2015-01-30 2016-08-04 Jds Therapeutics, Llc Chromium compositions for the treatment or prevention of diabetic retinopathy
EP3697433A4 (en) 2017-10-19 2021-07-21 Buice, Mona, E. TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS

Also Published As

Publication number Publication date
IL274002A (en) 2020-05-31
US20190290736A1 (en) 2019-09-26
EP3697433A4 (en) 2021-07-21
AU2024202400A1 (en) 2024-05-02
US12383607B2 (en) 2025-08-12
CA3079544A1 (en) 2019-04-25
US20230330190A1 (en) 2023-10-19
EP3697433A1 (en) 2020-08-26
US20210162015A1 (en) 2021-06-03
IL323598A (en) 2025-11-01
US20250025534A1 (en) 2025-01-23
MA50414A (fr) 2020-08-26
IL274002B1 (en) 2025-11-01
US11369664B2 (en) 2022-06-28
AU2018351352A1 (en) 2020-05-28
MX2025011487A (es) 2025-11-03
WO2019079710A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
ZA202007149B (en) High elasticity hyaluronan compositions and methods of use thereof
PH12020550857A1 (en) Polycyclic compounds as allosteric shp2 inhibitors
AU2018243463A8 (en) 11,13-modified saxitoxins for the treatment of pain
PH12015501987A1 (en) Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis
MX2016007779A (es) Formacion de fibras de queratina mediante el uso de ester de carbonato.
MX2025011487A (es) Composicion topica para cicatrizacion mejorada de heridas abiertas
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2019008999A (es) Composicion inyectable para prevenir la perdida del pelo o estimular el crecimiento del pelo.
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
GB201206486D0 (en) Vesicular formulations and uses thereof
WO2018094023A3 (en) Cyclic dipeptides and wound healing
MX357888B (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
NZ630346A (en) Injectable depot formulation comprising optically active tolvaptan and process of producing the same
WO2018105941A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
MX2018002921A (es) Composicion de hormona foliculo-estimulante mamifera con estabilidad incrementada.
EP4410370A3 (en) Compositions for promoting the healing of wounds
MX373977B (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
WO2019099860A3 (en) Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
MX2016007955A (es) Pirrol carboxamidas iii fluorometil-sustituidas.
MX2021010088A (es) Composicion topica para mejorar la curacion de las dolencias oculares.
WO2015112866A3 (en) Compounds and methods for increasing hair growth
MX2016007956A (es) Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2.
MX2016007951A (es) Pirrol carboxamidas iv fluorometil-sustituidas.
MX2022013816A (es) Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello.
PE20170293A1 (es) Compuesto estimulador del colageno y elastina y composiciones topicas que comprenden dicho compuesto